Sign Out
Active immunisation against tetanus and diphtheria
Adult: In patients who have not been immunised previously against tetanus and diphtheria: Primary immunisation: 0.5 mL for 3 doses. The 1st and 2nd dose are given 4-8 weeks apart, then a 3rd dose is given 6-12 months after the 2nd dose. Booster dose: 0.5 mL every 10 years. All doses are to be given via IM inj in the deltoid muscle. Recommendations and vaccination schemes may vary among countries or individual products. Refer to country- or product-specific guidelines.
Child: As diphtheria toxoid 25 limit of flocculation (Lf) and tetanus toxoid 5 Lf per 0.5 mL susp for inj: Infants and children 6 weeks through <7 years In patients with contraindications to pertussis-containing vaccines: Primary series: 0.5 mL for 3 doses given at 2-, 4-, and 6 months of age. Booster dose: 1st dose: 0.5 mL given at approx 15-18 months of age. 2nd dose: 0.5 mL given at 4-6 years of age. As diphtheria toxoid 2 Lf and tetanus toxoid 2 Lf per 0.5 mL susp for inj or diphtheria toxoid 2 Lf and tetanus toxoid 5 Lf per 0.5 mL susp for inj: ≥7 years Same as adult dose. Routine booster immunisation against diphtheria and tetanus is recommended in children 11-12 years and every 10 years thereafter. Recommendations and vaccination schemes may vary among countries or individual products. Refer to country- or product-specific guidelines.
Child: As diphtheria toxoid 25 limit of flocculation (Lf) and tetanus toxoid 5 Lf per 0.5 mL susp for inj: Infants and children 6 weeks through <7 years In patients with contraindications to pertussis-containing vaccines: Primary series: 0.5 mL for 3 doses given at 2-, 4-, and 6 months of age. Booster dose: 1st dose: 0.5 mL given at approx 15-18 months of age. 2nd dose: 0.5 mL given at 4-6 years of age. As diphtheria toxoid 2 Lf and tetanus toxoid 2 Lf per 0.5 mL susp for inj or diphtheria toxoid 2 Lf and tetanus toxoid 5 Lf per 0.5 mL susp for inj: ≥7 years Same as adult dose. Routine booster immunisation against diphtheria and tetanus is recommended in children 11-12 years and every 10 years thereafter. Recommendations and vaccination schemes may vary among countries or individual products. Refer to country- or product-specific guidelines.
Intramuscular
Prophylaxis of tetanus in wound management
Adult: Treatment and dosage recommendations may vary depending on the immunisation status of the patient (including the time from last tetanus-containing vaccine) and the type and condition of the wound; recommendations may also vary among countries or individual products. Refer to country- or product-specific product guidelines.
Child: ≥7 years Same as adult dose.
Child: ≥7 years Same as adult dose.
